CIK 0001819790
- Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 814717861
- Phone
- +1 949-409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,995,859
- in 7 filings, $6.0M under 10b5-1 plans
Net −$5,995,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-15 | Azamian Bobak R. President/CEO and Board Chair | Exercise or conversion · Restricted Stock Units | −11,299 | 33,898 | ||
| 2023-03-15 | Greenstein Leonard M. Chief Financial Officer | Exercise or conversion | +4,462 | 38,751 | ||
| 2023-03-15 | Greenstein Leonard M. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −4,462 | 13,388 | ||
| 2023-03-15 | LINK WILLIAM J PHD Director | Other disposition | −215,575 | 215,576 | ||
| 2023-03-15 | LINK WILLIAM J PHD Director | Other acquisition | +52,194 | 68,673 | ||
| 2023-03-15 | Holdbrook Mark J. V.P., Clinical Affairs | Exercise or conversion | +2,653 | 3,764 | ||
| 2023-03-15 | Holdbrook Mark J. V.P., Clinical Affairs | Exercise or conversion · Restricted Stock Units | −2,653 | 7,959 | ||
| 2023-03-15 | Wahl Bryan General Counsel | Exercise or conversion | +4,790 | 18,513 | ||
| 2023-03-15 | Wahl Bryan General Counsel | Exercise or conversion · Restricted Stock Units | −4,790 | 14,370 | ||
| 2023-03-15 | Whitfield Dianne C. Chief Human Resources Officer | Exercise or conversion | +4,462 | 13,185 | ||
| 2023-03-15 | Whitfield Dianne C. Chief Human Resources Officer | Exercise or conversion · Restricted Stock Units | −4,462 | 13,388 | ||
| 2023-03-15 | Trevejo Jose M. Chief Medical Officer | Exercise or conversion | +7,549 | 9,153 | ||
| 2023-03-15 | Trevejo Jose M. Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −7,549 | 22,648 | ||
| 2023-03-15 | Mottiwala Aziz Chief Commercial Officer | Exercise or conversion | +4,790 | 54,940 | ||
| 2023-03-15 | Mottiwala Aziz Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −4,790 | 14,370 | ||
| 2023-03-15 | Neervannan Seshadri Chief Operating Officer | Exercise or conversion | +5,097 | 56,934 | ||
| 2023-03-15 | Neervannan Seshadri Chief Operating Officer | Exercise or conversion · Restricted Stock Units | −5,097 | 15,291 | ||
| 2023-03-09 | Azamian Bobak R. President/CEO and Board Chair | Sale | −717 | $15.01 | $11K | 1,088,536 |
| 2023-03-08 | Azamian Bobak R. President/CEO and Board Chair | Sale | −4,853 | $15.02 | $73K | 1,089,253 |
| 2023-03-08 | Whitfield Dianne C. Chief Human Resources Officer | Grant or award · Stock Option (right to buy) | +42,802 | 42,802 |
Page 23 of 24 · 469 trades